PlainRecalls
FDA Drug Low Class III Terminated

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

Reported: September 13, 2023 Initiated: August 14, 2023 #D-1144-2023

Product Description

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Caplin Steriles Limited
Units Affected
19, 820 vials
Distribution
Nationwide in Tennessee
Location
Gummidipoondi, N/A

Frequently Asked Questions

What product was recalled?
Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10. Recalled by Caplin Steriles Limited. Units affected: 19, 820 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on September 13, 2023. Severity: Low. Recall number: D-1144-2023.